³» ¿ë |
I love the theatre http://9taxi.in.net/ taxi69 ** Drugmaker Retrophin Inc on Wednesday said itoffered to buy the rest of Transcept Pharmaceuticals Inc shares it does not already own for $4 per share,valuing Transcept at about $75 million. Retrophin"s offerrepresents an 11 percent premium to Transcept"s closing shareprice of $3.59 on the Nasdaq on Wednesday. |